Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 Dec 26;11(1):44.
doi: 10.3390/nu11010044.

The Effects of Oral Magnesium Supplementation on Glycemic Response among Type 2 Diabetes Patients

Affiliations
Randomized Controlled Trial

The Effects of Oral Magnesium Supplementation on Glycemic Response among Type 2 Diabetes Patients

Wafaa A ELDerawi et al. Nutrients. .

Abstract

Background: Magnesium (Mg) supplementation may help control glycemic response among type 2 diabetes (T2D) patients.

Objective: This study means to determine whether Mg supplementation improves glycemic control indicators in patients with T2D.

Methods: After one week of the dietary stabilization phase, 42 T2D patients were stratified according to sex, age, fasting blood sugar (FBS) and Mg levels and then randomly allocated into two groups. The intervention group was on 250 mg/day of elemental Mg for three months while the control group did not receive any type of supplements throughout the intervention period.

Results: The daily administration of 250 mg of elemental Mg indicated a significant improvement in HbA1C (8.32 to 7.96%, p < 0.001), insulin levels (IL) (15.56 to 12.18 μIU/mL, p < 0.001), C-peptide (2.28 to 1.90 ng/mL, p = 0.001), HOMA.IR (6.16 to 4.44, p < 0.001) and HOMA.β% (59.99 to 52.37, p = 0.036) of the intervention group when compared with the control group after three months of intervention.

Conclusion: The results of this study revealed that oral Mg supplementation reduces insulin resistance and improves the glycemic control indicators among T2D patients.

Trial registration: current controlled trials PHRC/HC/32/15. Registered 5 October 2015.

Keywords: blood glucose; diabetes mellitus; insulin; magnesium.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Suppl. 1):S62–S69. doi: 10.2337/dc10-S062. - DOI - PMC - PubMed
    1. Skyler J.S. Transplantation of the Pancreas. Springer; New York, NY, USA: 2004. Diabetes mellitus: Pathogenesis and natural history; pp. 11–27.
    1. World Health Organization . Global Report on Diabetes. WHO; Geneva, Switzerland: 2016.
    1. Mitri J., Pittas A.G. Vitamin D and diabetes. Endocrinol. Metab. Clin. 2014;43:205–232. doi: 10.1016/j.ecl.2013.09.010. - DOI - PMC - PubMed
    1. Hamed A.T., Al Zinati S.M., Al Swirky A. The Effect of Vitamin C Alone or in Combination with Vitamin E on Fasting Blood Glucose, Glycosylated Hemoglobin and Lipid Profile in Type 2 Diabetic Patients (Gaza Strip) Jordan J. Pharm. Sci. 2016;9:1–12. doi: 10.12816/0029864. - DOI

Publication types